Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DNA

Ginkgo Bioworks Holdings, Inc.

CIK 0001830214 · NYSE

NYSEHealth CareBiological Products, (No Diagnostic Substances)
$7.40
↑ 0.44 (6.32%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$409.84M
P/E Ratio
-1.41
EPS
-5.64
Dividend Yield
Not covered
52W Position
17%
Beta
3.10

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.98
P/S
3.66
EV/Revenue
2.91
ROE
-69.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 17%
$5.37$17.58

Latest Financials

2025-12-31 FY
Revenue
$170.16M
Net Income
-$312.76M
Total Assets
$1.12B
Free Cash Flow
-$178.72M

Recent news